David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Theravance Biopharma
TBPH
$884M
| $7.7M | 0.01% |
444,031
-196,608
| -31% | -$3.6M |
|
1102
Lam Research
LRCX
$394B
| $7.7M | 0.01% |
1,095,590
-4,143,490
| -79% | -$32.8M |
|
1103
PUT
Allegiant Air
ALGT
$2.25B
| $7.69M | 0.01% |
+40,000
| New | +$7.17M |
|
1104
Thomson Reuters
TRI
$45.2B
| $7.69M | 0.01% |
163,464
-33,692
| -17% | -$1.55M |
|
1105
PUT
Trinity Industries
TRN
$2.36B
| $7.65M | 0.01% |
299,191
-550,738
| -65% | -$12M |
|
|
AIRM
1106
DELISTED
Air Methods Corp
AIRM
| $7.63M | 0.01% |
+163,824
| New | +$7.5M |
|
1107
CALL
Altria Group
MO
$114B
| $7.63M | 0.01% |
152,500
-677,900
| -82% | -$36M |
|
1108
RPM International
RPM
$13.6B
| $7.61M | 0.01% |
158,532
+150,352
| +1,838% | +$7.27M |
|
1109
PUT
Cencora
COR
$62.6B
| $7.57M | 0.01% |
66,600
+38,600
| +138% | +$3.88M |
|
1110
Unisys
UIS
$196M
| $7.57M | 0.01% |
325,971
+95,974
| +42% | +$2.34M |
|
1111
PUT
Air Products & Chemicals
APD
$67.7B
| $7.56M | 0.01% |
54,050
+10,810
| +25% | +$1.5M |
|
1112
CALL
Hershey
HSY
$37.6B
| $7.55M | 0.01% |
74,800
+30,000
| +67% | +$3.13M |
|
1113
CALL
APA Corp
APA
$14.5B
| $7.52M | 0.01% |
124,700
+62,500
| +100% | +$3.93M |
|
|
CIVI
1114
DELISTED
Civitas Resources
CIVI
| $7.51M | 0.01% |
2,728
+2,598
| +1,998% | +$7.43M |
|
1115
PUT
Kohl's
KSS
$2B
| $7.5M | 0.01% |
95,800
+10,000
| +12% | +$681K |
|
1116
Eastman Chemical
EMN
$8.23B
| $7.46M | 0.01% |
107,776
+59,081
| +121% | +$4.27M |
|
1117
Portland General Electric
POR
$5.86B
| $7.45M | 0.01% |
200,965
-180,771
| -47% | -$6.82M |
|
1118
CALL
Helmerich & Payne
HP
$4.21B
| $7.45M | 0.01% |
109,400
-49,700
| -31% | -$3.25M |
|
1119
CALL
Travelers Companies
TRV
$77.1B
| $7.44M | 0.01% |
68,800
-171,200
| -71% | -$18.3M |
|
|
HOS
1120
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $7.43M | 0.01% |
394,998
+284,954
| +259% | +$5.93M |
|
|
SYA
1121
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $7.41M | 0.01% |
315,982
-19,866
| -6% | -$444K |
|
1122
Rigel Pharmaceuticals
RIGL
$873M
| $7.41M | 0.01% |
207,598
+51,866
| +33% | +$1.42M |
|
1123
Transocean
RIG
$6.42B
| $7.41M | 0.01% |
505,114
-3,059,784
| -86% | -$49.6M |
|
|
SLCA
1124
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.41M | 0.01% |
208,100
-20,000
| -9% | -$584K |
|
1125
PUT
PVH
PVH
$3.44B
| $7.39M | 0.01% |
69,400
-10,500
| -13% | -$1.14M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.